Walker Marlan D
- SEC CIK
- 0001820187
No open-market purchases or sales filed in the past year.
Current role at each company
- TXMD TherapeuticsMD, Inc.Chief Executive Officeras of Nov 5, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Walker Marlan D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2025 (view filing) | Apr 14 | 1 day | Walker Marlan DChief Executive Officer | PPurchase | +490 | $1.00 | +$490 | +0.7%73.6K after | |
| Apr 10, 2025 (view filing) | Apr 9-10 | 1 day | Walker Marlan DChief Executive Officer | PPurchase | +2.30K | $0.8649 | +$1.99K | +3.3%73.1K after | 2 lots |
| Dec 7, 2023 (view filing) | Dec 6-7 | 1 day | Walker Marlan DChief Executive Officer | SSale | −19.1K | $2.29 | −$43.7K | −23.3%62.6K after | 2 lots |
| May 4, 2023 (view filing) | Apr 26 | 8 days | Walker Marlan DChief Executive Officer | SSale | −692 | $3.64 | −$2.52K | −5.6%11.6K after | Amended |
| Apr 14, 2023 (view filing) | Apr 12 | 2 days | Walker Marlan DChief Executive Officer | SSale | −1.17K | $3.65 | −$4.27K | −8.7%12.3K after | From original |
| Dec 9, 2022 (view filing) | Dec 6 | 3 daysLate | Walker Marlan DGeneral Counsel | SSale | −1.05K | $4.95 | −$5.19K | −13.6%6.68K after |